SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

MSI NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

NOVARTIS: Click to view the issuer\'s details

Last update : 28/01/2011  >View issuer details

2021.01.11 | 22:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene - HTML (w)

2020.12.18 | 22:50 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis receives complete response letter from U.S. FDA for inclisiran - HTML (w)

2020.12.14 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis provides update on RUXCOVID study of ruxolitinib for hospitalized patients with COVID-19 - HTML (w)

2020.12.09 | 15:45 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis Kisqali® data demonstrate superior benefit across main intrinsic subtypes in metastatic breast cancer - HTML (w)

2020.12.09 | 15:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis Kisqali® demonstrates nearly five years median overall survival in metastatic breast cancer - HTML (w)

2020.11.19 | 22:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis secures exclusive rights for potential acute respiratory distress syndrome cell therapy - HTML (w)

2020.11.19 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis set to achieve 100% renewable electricity in its European operations - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 1384